177A.T
Kohjin Bio Co.,Ltd.
グロース · 化学 · 素材・化学 · JP
JPY 846.00
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | 5.1B | 4.9B | 5.2B | 4.8B |
| Cost of Revenue | 731.9M | 3.1B | 2.8B | 2.9B |
| Gross Profit | 487.7M | 1.9B | 2.4B | 1.9B |
| Operating Expenses | ||||
| R&D Expense | — | — | — | — |
| SG&A Expense | 356.6M | 1.5B | 1.4B | 1.3B |
| General & Admin Expense | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — |
| Other Expenses | — | — | — | — |
| Total Operating Expenses | 356.6M | 1.5B | 1.4B | 1.3B |
| Cost and Expenses | 4.4B | 4.6B | 4.2B | 4.2B |
| Operating Income (EBIT) | 703.0M | 341.0M | 991.0M | 596.0M |
| Non-Operating | ||||
| Interest Income | 119.0K | 4.4M | 1.9M | 651.0K |
| Interest Expense | 9.8M | 38.1M | 30.1M | 22.9M |
| Net Interest Income | (9.7M) | (33.6M) | (28.1M) | (22.2M) |
| Other Non-Op Income/Expense | (14.6M) | (586.0K) | 74.3M | 38.8M |
| Non-Operating Income (excl Interest) | 14.8M | 54.9M | 116.0M | 93.1M |
| EBT (Pre-Tax Income) | 116.5M | 332.3M | 1.0B | 635.6M |
| Income Tax Expense | 34.2M | 81.2M | 220.5M | 250.6M |
| Bottom Line | ||||
| Net Income | 557.0M | 251.0M | 794.0M | 384.0M |
| Earnings from Cont. Ops | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — |
| Bottom Line Net Income | 557.0M | 251.0M | 794.0M | 384.0M |
| Per Share | ||||
| Basic EPS | ¥110 | ¥49 | ¥158 | ¥92 |
| Diluted EPS | ¥110 | ¥49 | — | ¥92 |
| Revenue Per Share | ¥993 | ¥966 | ¥1,032 | ¥1,145 |
| Shares | ||||
| Basic Shares Outstanding | 5.1M | 5.1M | 5.0M | 4.2M |
| Diluted Shares Outstanding | — | — | — | — |
| Profitability Metrics | ||||
| EBITDA | — | 737.1M | 1.4B | 895.6M |
| D&A | — | 396.1M | 361.0M | 299.6M |
| EBIT | 703.0M | 341.0M | 991.0M | 596.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026